| CAS登錄號(hào) | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 70474-76-9 | Grayanotox-10(20)-ene-3,5,6,16-tetrol,(3b,6b)-; 7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotox-10(20)-ene-3,5,6,16-tetrol deriv.; Grayanotoxin XVIII |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 59404-25-0 | Hexanoic acid,2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenoxy]-; 2-(3,5-Di-tert-butyl-4-hydroxyphenoxy)hexanoicacid; NSC 297621 |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 69121-59-1 | Kaur-16-ene-2,6,14,15-tetrol,(2b,6b,14R,15a)-; PterokauraneP3 |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 141947-35-5 | Kauran-18-oic acid,17,19-dihydroxy-, (4a,16a)-; (-)-Seigesbeckicacid; Seigesbeckic acid |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 3301-61-9 | Kauran-18-oic acid,16,17-dihydroxy-, (4a)-; Kauran-18-oicacid, 16,17-dihydroxy- (7CI,8CI); 1H-2,10a-Ethanophenanthrene, kauran-18-oicacid deriv.; (-)-16,17-Dihydroxy-16b-kauran-19-oic acid; 16,17-Dihydroxy-16b-(-)-kauran-19-oic acid; 16a,17-Hydroxy-(-)-kauran-19-oic acid; 16b,17-Dihydroxy-ent-kauran-19-oicacid; ent-16,17-Dihydroxykauran-19-oic acid; ent-16b,17-Dihydroxykauran-19-oic acid |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 14152-28-4 | 前列腺素 A1 | Prosta-10,13-dien-1-oicacid, 15-hydroxy-9-oxo-, (13E,15S)-; 3-Cyclopentene-1-heptanoicacid, 2-(3-hydroxy-1-octenyl)-5-oxo- (8CI); 15-Hydroxy-9-oxoprosta-10,13-dienoicacid; 15a-Hydroxy-9-ketoprosta-10,13-dienoicacid; 15a-Hydroxy-9-oxo-10,13E-prostadienoicacid; PGA1; Prostaglandin A1; Prostaglandin E1-217 |  | C20H32O4 | 詳情 | 供應(yīng)商 |
| 13345-51-2 | 前列腺素B1; (13E,15S)-15-羥基-9-氧代前列腺-8(12),13-二烯-1-膽酸 | Prosta-8(12),13-dien-1-oicacid, 15-hydroxy-9-oxo-, (13E,15S)-; 1-Cyclopentene-1-heptanoicacid, 2-(3-hydroxy-1-octenyl)-5-oxo- (7CI,8CI); 15-Hydroxy-9-oxoprosta-8(12),13-dienoicacid; 15a-Hydroxy-9-ketoprosta-8(12),13-dienoicacid; 15a-Hydroxy-9-oxo-8(12),13E-prostadienoicacid; PGB1; PGE1-278; Prostaglandin B1; Prostaglandin E1-278 |  | C20H32O4 | 詳情 | 供應(yīng)商 |
| 20897-92-1 | Prosta-10,13-dien-1-oicacid, 15-hydroxy-9-oxo-, (13E,15R)- (9CI); 3-Cyclopentene-1-heptanoicacid, 2-(3-hydroxy-1-octenyl)-5-oxo-, stereoisomer (8CI) |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 55314-49-3 | Prosta-5,13-dien-1-oicacid, 9,11,15-trihydroxy-, l-lactone, (5Z,9a,11a,13E,15S)- (9CI); 5H-Cyclopent[e]oxacyclotridecin,prosta-5,13-dien-1-oic acid deriv.; PGF2a 1,15-lactone; U 47473 |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 5829-13-0 | Propanedioic acid,(3,7-dimethyl-2,6-octadienyl)-2-propenyl-, diethyl ester, (E)- (9CI); Malonic acid, allyl(3,7-dimethyl-2,6-octadienyl)-,diethyl ester, (E)- (8CI) |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 94277-25-5 | Propanoic acid,2-methyl-, (octahydro-4,7-methano-1H-indene-5,?-diyl)bis(methylene) ester (9CI) |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 35536-53-9 | Prosta-5,13-dien-1-oicacid, 15-hydroxy-9-oxo-, (5Z,13E,15S)-; 11-Deoxy-PGE2; 11-Deoxyprostaglandin E2; 15(S)-Hydroxy-9-oxoprosta-5-cis-13-trans-dienoicacid; 15a-Hydroxy-9-keto-prosta-5,13-dienoicacid; Wy 18189; ZK 73-466 |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 28644-72-6 | 1-Naphthalenepentanoicacid, 5-carboxy-1,2,3,4,4a,7,8,8a-octahydro-b,1,2,4a-tetramethyl- (9CI); 17,19-Dinor-5b,8x-labd-3-ene-15,18-dioic acid, 5,9-dimethyl- (8CI); Cistodioic acid |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 5956-15-0 | 1-Naphthalenepentanoicacid, 5-carboxydecahydro-b,5,8a-trimethyl-2-methylene-, (1S,4aR,5S,8aR)-; 1-Naphthalenepentanoicacid, 5-carboxydecahydro-b,5,8a-trimethyl-2-methylene-, [1S-(1a,4ab,5a,8aa)]-[partial]-; Labd-8(20)-ene-15,19-dioic acid(7CI,8CI); Agathic acid, dihydro- |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 1412-99-3 | 1-Naphthalenepentanoicacid, 5-carboxydecahydro-b,5,8a-trimethyl-2-methylene-, (bS,1S,4aR,5R,8aR)-; 1-Naphthalenepentanoicacid, 5-carboxydecahydro-b,5,8a-trimethyl-2-methylene-, [1S-[1a(R*),4ab,5b,8aa]]-; Labd-8(20)-ene-15,18-dioic acid, (13S)- (8CI); Pinifolic acid (7CI) |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 29455-26-3 | 1-Naphthalenepentanoicacid, 5-carboxydecahydro-b,5,8a-trimethyl-2-methylene-, (bR,1R,4aS,5R,8aS)-; 1-Naphthalenepentanoicacid, 5-carboxydecahydro-b,5,8a-trimethyl-2-methylene-, [1R-[1a(R*),4ab,5a,8aa]]-; 5b,9bH,10a-Labd-8(20)-ene-15,18-dioic acid, (13R)- (8CI); Oliveric acid |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 154187-42-5 | 2,5-Cyclohexadiene-1,4-dione,2-decyl-5-ethoxy-6-methoxy-3-methyl-; 6-decyl-3-ethoxy-2-methoxy-5-methyl-1,4-benzoquinone |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 154187-41-4 | 2,5-Cyclohexadiene-1,4-dione,2-decyl-6-ethoxy-5-methoxy-3-methyl-; 6-decyl-2-ethoxy-3-methoxy-5-methyl-1,4-benzoquinone |  | C20H32O4 | 詳情 | 供應(yīng)商 | |
| 71774-10-2 | 12-(S)-過氧化氫-5Z,8Z,10E,14Z-二十碳四烯酸 | 5,8,10,14-Eicosatetraenoicacid, 12-hydroperoxy-, (5Z,8Z,10E,12S,14Z)-; 5,8,10,14-Eicosatetraenoicacid, 12-hydroperoxy-, [S-(E,Z,Z,Z)]-; 12(S)-HPETE; 12(S)-Hydroperoxy-5Z,8Z,10E,14Z-eicosatetraenoicacid |  | C20H32O4 | 詳情 | 供應(yīng)商 |
| 70981-96-3 | 15-羥基二十碳-5Z,8Z,11Z,13E-四烯酸 | 5,8,11,13-Eicosatetraenoicacid, 15-hydroperoxy-, (5Z,8Z,11Z,13E,15S)-; 5,8,11,13-Eicosatetraenoicacid, 15-hydroperoxy-, [S-(E,Z,Z,Z)]-; 15(S)-HPETE; 15-HPETE; [S-(E,Z,Z,Z)]-15-Hydroperoxyeicosatetraenoicacid |  | C20H32O4 | 詳情 | 供應(yīng)商 |